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Abstract
Introduction: One of the rare manifestations of systemic neoplasia is intramedullary spinal cord
metastasis that causes serious diagnostic and therapeutic dilemma. It has been very rarely reported as
the initial manifestation of carcinoma. This is report of a metastatic renal cell carcinoma initially
presented with intramedullary spinal cord lesion, to our knowledge there are few similar reports in
literature.
Case presentation: We report a 51-year-old Iranian woman who presented with back pain and
paraparesis. MR imaging study of her spine showed an enhancing cystic lesion at the level of conus
medullaris. Despite detailed investigation, no specific aetiology was found till a bone scan obtained to
evaluate an agonizing pain on the dorsum of the left hand revealed photon deficient area within the
left kidney in addition to oseoblastic bony lesions. After thorough imaging investigation she
underwent radical nephrectomy which confirmed renal cell carcinoma.
Conclusion: Considering the prevalence of cancer, it is imperative that clinicians be mindful of
occult carcinoma as the cause of suspicious intramedullary spinal cord lesion.
Introduction
Carcinoma metastases of the spinal cord are rare diseases;
the least frequent of which, is intramedullay spinal cod
metastasis (ISCM) that causes serious diagnostic and
therapeutic problems [1,2], however, despite it’s rarity,
intramedullarymetastasisshouldbeconsideredinpatients
with systemic malignancy presenting with myelopathic
symptoms[3].Therecognitionofintrameullaryspinalcord
metastasis is an ominous finding as it generally occurs in
the setting of widespread systemic and intracranial disease
and is the prelude to cancer death by a few months [4].
The presenting symptoms of ISCM vary from pain,
sensory loss, weakness, urinary incontinence to pseudo
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duration of symptoms before diagnosis of ISCM ranges
from days to a few months [5,6]. The very rare occurrence
of ISCM and the absence of pathognomic symptoms often
lead to an undue delay until the underlying malignancy is
discovered [7]. Considering the widely disseminated
nature of the underlying malignancy at the time of
diagnosis, ISCM is generally associated with poor survival
and portends itself as a dismal finding within the context
of a systemic cancer; heralding cancer death by a few
months [6,8,9]. Surgery and radiotherapy have been
recommended controversially in the treatment of ISCM.
Although long-term survival is poor, treatment may
preserve ambulation in the case of early diagnosis; it
may also stabilize neurological function and this may
change the patient’s health related quality of life unbelie-
vably [5,7,11]. Heightened awareness of this entity may
lead to early diagnosis at a stage when neurological deficits
may be reversible and more effective palliation may be
expected.
Case presentation
A 51-year-old Iranian woman presented with 2-month
history of progressive unremitting back pain, exacerbated
at night, superimposed on a creeping paraparesis. She also
suffered from episodes of urinary retention for which she
had undergone thorough clinical examination and a series
of investigation including neuroimaging, cerebrospinal
fluid analysis and also serologic surveys to find the
aetiology. MR imaging of the brain and spine revealed
one non-enhancing cystic lesion without surrounding
enhancement located within the left cerebral hemisphere
and another one at the level of conus medullaris in the
spine (Figure 1). No infectious aetiology had been found
despite performing detailed investigation to detect any
sign of cysticercosis, brucellosis and/or HTLV infection.
The tissue biopsy of the involved area was not obtained as
she had not consented to it. An extremely painful
induration with indistinct border was found over the
dorsum of the left hand. X-Ray imaging showed osteolysis
of the second metacarpal bone (Figure 2). The other sites
of body skeleton were normal on examination despite her
complaint about the agonizing pain over most parts of her
body. 99 m Tc-DTPA revealed increased uptake of radio-
tracer in axial skeleton and left hand area and, also a
photon-deficient area adjacent to the lower pole of the left
kidney suggestive of a space occupying lesion originating
from that kidney (Figure 3).
Complex cystic renal mass lesion was revealed on
ultrasonography which was found to be hypervascular
on contrast-enhanced CT scan. The result of imaging
investigations was compatible with renal cell carcinoma
diagnosis, till otherwise proved. In the meantime, the
patient was hospitalized for nutritional supplementation
and other supportive care. Radical nephrectomy was done
afterwards and the histology confirmed renal cell carci-
noma with sarcomatous component. Early in postopera-
tive period she developed .thromboses in proximal veins
of left lower extremity for which she received enoxaparin
60 mg twice daily subcutaneousely. She also had severe
hypercalcemia probably due to paraneoplastic effect of the
tumour producing PTHrP, and widespread bony meta-
stases as the intact PTH assay was undetectable. She
received appropriate treatment for her hypercalcemia.
The patient and her family refused to accept further
treatment when they were informed regarding the natural
Figure 1. MR imaging of the spine at the level of conus
medullaris. A non enhancing cystic lesion is seen in the area.
Figure 2. X-Ray imaging of the left hand showing
osteolytic lesion of the second metacarpal bone.
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limitations of the currently available treatment, and she
was lost for further follow up.
Discussion
Spinal metastases may be seen in as much as 70% of
patients with systemic neoplasia. Among these lesions,
intramedullary spinal metastases are rare, comprising only
0.5% of spinal axis metastases. Majority of them arise from
the lung neoplasia ,with small cell carcinoma being the
predominant histological subtype. Breast, colorectal,
renal, melanoma, thyroid and lymphoma have all infre-
quently been reported to be the origin. The lesions are
found most often in patients with concomitant brain
metastasis [12]. However, metastasis to the intramedullary
spinal cord is extremely rare as the initial sign of a
disseminated carcinoma [9]. The lesions are believed to
result from leptomeningeal carcinomatosis with subse-
quent cerebrospinal fluid spread or as a result of
hematogenic emboli from a pulmonary lesion [5,13,14];
but the patient in our report had no evidence of
leptomeningeal or pulmonary involvement. In patients
without history of systemic neoplasia such as the patient
in our report, a knowledgeable clinical history and a hands
on physical examination coupled with selected laboratory
and diagnostic imaging investigations may delineate
primary or secondary spinal malignant lesions from
other more benign differential diagnostic entities. MRI is
useful in determining the extent of CNS involvement
which may affect the therapeutic decision making in many
patients [12,15]. Pain, weakness, sensory deficits and
bowel/bladder dysfunction are the presenting complaints
of ISCM. Germ et al reported pain and weakness to be the
most frequent. Among the 55 patients reviewed by them,
bowel and bladder dysfunctions were unusual early
manifestations of intramedullary spinal cord metastasis
probably because the time course from the onset of
neurologic symptoms to the development of the full
blown neurological deficit was short [4]. According to
Schiff and O’ Nill , median duration of symptoms at the
diagnosis was 28 days (ranged from 3 days to 18 months);
median survival was 4 months for patients receiving
radiotherapy and 2 months for those not receiving
radiotherapy [5]. Their finding was consistent with that
of Germ et al who found that more than 80% of patients
died within three months after diagnosis of ISCM [4].
The prognosis of a patient who has an intramedullary cord
lesion is grave, the treatment is mostly undertaken to
relieve pain and to preserve or stabilize neurologic
function. Medical and surgical interventions and radio-
therapy have controversially been used as a therapeutic
modality. The management of patients has evolved greatly
over the last decade. Spine surgeons are playing greater
role in the management of patients with metastatic
disease. With the advent of new surgical strategies many
patients may benefit from effective treatment modalities
ranging from radical, open excision through minimally
invasive surgery such as endoscopy to ultraminimal/
noninvasive spinal radiosurgery. Radiotherapy may no
longer be considered as the first line therapeutic modality.
Making an early diagnosis of ISCM is useful in planning
either early or no major intervention. Providing patients
with successful palliation and improving their quality of
life demand multidisciplinary strategic treatment planning
[12,16].
Conclusion
This report presents the clinical and neuroradiological
features of an extremely unusual presentation of renal cell
carcinoma as intramedullary spinal cord lesion.
Abbreviation
MR, Magnetic resonance.
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